Though the exact mechanism still needs to be elucidated, the present study indicated that leukemia-derived ST2+ Treg cells from BM or spleen preferentially kill leukemia-primed (TME) CD8 T cells and not CD45RA-sorted naïve or non-TME CD8 T cells. Here, IL1RL1 is linked to leukemia.